99mtc-annexin-v-128
Recombinant proteinexperimentalImaging agent
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Feb 5, 2016 (NCT02459613)
Timeline
Indications
Mechanism of action
- Annexin A5Supplementation
ANXA5 supplementation
Chemistry & pharmacology
- Multi-specific
- No
- Imaging
- 99-MTC
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03630835 | Phase 2/Phase 3 (Phase 3) | Sep 30, 2018 | Assistance Publique - Hôpitaux de Paris |
| NCT02459613 | Phase 1/Phase 2 (Phase 2) | Feb 5, 2016 | Advanced Accelerator Applications, Assistance Publique - Hôpitaux de Paris, Institut National de la Santé Et de la Recherche Médicale, France |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Assistance Publique - Hôpitaux de Paris | Academic/Hospital | 2 | 1 | 2 | 2016 |
| Advanced Accelerator Applications | For profit | 1 | 0 | 1 | 2016 |
| Institut National de la Santé Et de la Recherche Médicale, France | Academic/Hospital | 1 | 1 | 1 | 2016 |
3 organizations
Page 1 / 1